Prognostic value of Short Physical Performance Battery in older patients with Stage B heart failure: a prospective

Chen Ji1, Min Zeng2,3, Ning Sun2

  • 1Beijing Hospital, National Centre of Gerontology, Beijing, China.

BMC Geriatrics
|December 6, 2025
PubMed

Insights

The Short Physical Performance Battery (SPPB) can predict mortality in older adults with Stage B heart failure. A threshold of 6 points on the SPPB, rather than 9, better identifies high-risk individuals.

Area of Science:

  • Gerontology
  • Cardiology
  • Clinical Epidemiology

Background:

  • Stage B heart failure (HF) risk stratification currently overlooks functional status.
  • The prognostic value of the Short Physical Performance Battery (SPPB) for mortality in older adults with Stage B HF is unknown.
  • This study assesses the SPPB's association with mortality and its incremental predictive value over conventional metrics.

Purpose of the Study:

  • To evaluate the association between SPPB and all-cause mortality in older adults with Stage B HF.
  • To establish an optimal SPPB threshold for risk stratification.
  • To determine the incremental prognostic value of SPPB and its subtests compared to traditional cardiac indicators.

Main Methods:

  • Prospective cohort study of 527 patients aged ≥65 years with Stage B HF, followed for 5 years.
  • Analysis of all-cause mortality using multivariable Cox regression and restricted cubic splines.
  • Evaluation of SPPB's incremental predictive value using AUC, IDI, cNRI, and DCA, with a focus on a 6-point threshold.

Main Results:

  • An SPPB threshold of ≤6 was associated with a threefold higher risk of all-cause mortality (HR=3.29).
  • The 6-point SPPB threshold demonstrated superior predictive performance (AUC=0.840) compared to the conventional 9-point threshold.
  • Gait speed, an SPPB subtest, provided the strongest incremental prognostic value (AUC=0.833).

Conclusions:

  • SPPB is an independent predictor of mortality in older adults with Stage B HF.
  • A 6-point SPPB threshold improves risk discrimination more effectively than the conventional 9-point threshold.
  • Incorporating SPPB, particularly gait speed, enhances prognostic assessment and risk stratification for Stage B HF.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
281
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
389
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
724